Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Here's What You Missed in Cannabis This Week » 11:29
02/02/23
02/02
11:29
02/02/23
11:29
IGC

India Globalization Capital

/

+

, TLRY

Tilray

$3.50 /

+0.16 (+4.80%)

, STMH

Stem Holdings

/

+

, INCR

InterCure

$3.81 /

+0.11 (+2.97%)

, HITI

High Tide

$1.60 /

+0.04 (+2.56%)

, FLGC

Flora Growth

/

+

, GNLN

Greenlane

/

+

, AYRWF

Ayr Wellness

$1.34 /

+0.059 (+4.61%)

, ACB

Aurora Cannabis

$1.14 /

+0.055 (+5.07%)

, CVSI

CV Sciences

/

+

, CTST

CannTrust

/

+

, CGC

Canopy Growth

$3.15 /

+0.08 (+2.61%)

, CRON

Cronos Group

$2.59 /

+0.065 (+2.58%)

, CANN

Trees Corporation

/

+

, GDNSF

Goodness Growth

/

+

, GTBIF

Green Thumb Industries

$8.45 /

+0.39 (+4.84%)

, TCNNF

Trulieve Cannabis

$6.75 /

+0.00599 (+0.09%)

, ZYNE

Zynerba

/

+

, ATAI

Atai Life Sciences

$1.90 /

+0.05 (+2.70%)

, CMPS

Compass Pathways

$10.74 /

+0.1 (+0.94%)

, RLMD

Relmada Therapeutics

$4.31 /

+0.05 (+1.17%)

In this week's "Rising…

ShowHide Related Items >><<
ZYNE Zynerba
/

+

TLRY Tilray
$3.50 /

+0.16 (+4.80%)

TCNNF Trulieve Cannabis
$6.75 /

+0.00599 (+0.09%)

STMH Stem Holdings
/

+

RLMD Relmada Therapeutics
$4.31 /

+0.05 (+1.17%)

INCR InterCure
$3.81 /

+0.11 (+2.97%)

IGC India Globalization Capital
/

+

HITI High Tide
$1.60 /

+0.04 (+2.56%)

GTBIF Green Thumb Industries
$8.45 /

+0.39 (+4.84%)

GNLN Greenlane
/

+

GDNSF Goodness Growth
/

+

FLGC Flora Growth
/

+

CVSI CV Sciences
/

+

CRON Cronos Group
$2.59 /

+0.065 (+2.58%)

CMPS Compass Pathways
$10.74 /

+0.1 (+0.94%)

CGC Canopy Growth
$3.15 /

+0.08 (+2.61%)

CANN Trees Corporation
/

+

AYRWF Ayr Wellness
$1.34 /

+0.059 (+4.61%)

ATAI Atai Life Sciences
$1.90 /

+0.05 (+2.70%)

ACB Aurora Cannabis
$1.14 /

+0.055 (+5.07%)

IGC India Globalization Capital
/

+

11/09/22 Bernstein
Two more states legalize cannabis, $3B added to TAM, says Bernstein
04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
TLRY Tilray
$3.50 /

+0.16 (+4.80%)

01/10/23 MKM Partners
Tilray price target lowered to $3 from $4 at MKM Partners
01/10/23 Canaccord
Tilray price target lowered to $5 from $7 at Canaccord
01/09/23 Alliance Global Partners
Tilray price target lowered to $3 from $4 at Alliance Global Partners
12/28/22 Piper Sandler
Tilray estimates lowered on softer beer sales at Piper Sandler
STMH Stem Holdings
/

+

INCR InterCure
$3.81 /

+0.11 (+2.97%)

05/17/22 Canaccord
InterCure upgraded to Buy from Speculative Buy at Canaccord
HITI High Tide
$1.60 /

+0.04 (+2.56%)

FLGC Flora Growth
/

+

12/19/22 Alliance Global Partners
Flora Growth price target lowered to $1.25 from $2 at Alliance Global Partners
10/24/22 Alliance Global Partners
Flora Growth price target lowered to $2 from $2.50 at Alliance Global Partners
09/23/22 Alliance Global Partners
Flora Growth initiated with a Buy at Alliance Global Partners
08/01/22 Cantor Fitzgerald
Cantor starts Flora Growth with Neutral amid diversification process
GNLN Greenlane
/

+

11/16/22 Alliance Global Partners
Greenlane price target lowered to $2 from $6 at Alliance Global Partners
11/01/22 Roth MKM
Greenlane downgraded to Neutral from Buy at Roth Capital
08/17/22 Alliance Global Partners
Greenlane price target raised to $6 from $1.50 at Alliance Global Partners
08/17/22 Canaccord
Greenlane price target lowered to $5 from $20 at Canaccord
AYRWF Ayr Wellness
$1.34 /

+0.059 (+4.61%)

01/30/23 Canaccord
Ayr Wellness downgraded to Speculative Buy from Buy at Canaccord
10/28/22 BTIG
Ayr Wellness initiated with a Buy at BTIG
08/19/22 Canaccord
Ayr Wellness price target lowered to C$30 from C$40 at Canaccord
08/19/22 Northland
Ayr Wellness price target lowered to $10 from $14 at Northland
ACB Aurora Cannabis
$1.14 /

+0.055 (+5.07%)

01/27/23 Stifel
Aurora Cannabis price target lowered to C$1.45 from C$1.75 at Stifel
12/28/22 Piper Sandler
Aurora Cannabis price target lowered to $1 from $2 at Piper Sandler
10/07/22 Stifel
Cannabis stocks could rise about three times in near-term, says Stifel
CVSI CV Sciences
/

+

CTST CannTrust
/

+

CGC Canopy Growth
$3.15 /

+0.08 (+2.61%)

02/01/23 CIBC
Canopy Growth price target lowered to C$2.50 from C$3 at CIBC
11/07/22 Canaccord
Canopy Growth price target raised to C$5 from C$4.25 at Canaccord
11/01/22 Bernstein
Bernstein starts Canopy Growth at Underperform, sees equity raise
CRON Cronos Group
$2.59 /

+0.065 (+2.58%)

11/08/22 Canaccord
Cronos Group price target lowered to C$4.75 from C$5 at Canaccord
11/01/22 Bernstein
Cronos started with Market Perform on limited visibility at Bernstein
11/01/22 Bernstein
Cronos Group initiated with a Market Perform at Bernstein
CANN Trees Corporation
/

+

GDNSF Goodness Growth
/

+

11/16/22 Canaccord
Goodness Growth price target lowered to C$0.85 from C$1 at Canaccord
10/14/22 Alliance Global Partners
Verano Holdings price target lowered to C$12 from C$16 at Alliance Global
05/12/22 Canaccord
Goodness Growth price target lowered to C$3.50 from C$4 at Canaccord
GTBIF Green Thumb Industries
$8.45 /

+0.39 (+4.84%)

12/01/22 Wedbush
Wedbush starts Green Thumb with Outperform, names top cannabis pick
12/01/22 Wedbush
Green Thumb Industries initiated with an Outperform at Wedbush
11/03/22 Stifel
Green Thumb Industries price target raised to C$31 from C$30.50 at Stifel
TCNNF Trulieve Cannabis
$6.75 /

+0.00599 (+0.09%)

12/01/22 Wedbush
Wedbush starts Trulieve with Outperform on broadening reach
12/01/22 Wedbush
Trulieve Cannabis initiated with an Outperform at Wedbush
11/10/22 Canaccord
Trulieve Cannabis price target lowered to C$50 from C$54 at Canaccord
ZYNE Zynerba
/

+

06/23/22 Canaccord
Zynerba price target raised to $11 from $9 at Canaccord
ATAI Atai Life Sciences
$1.90 /

+0.05 (+2.70%)

01/19/23 H.C. Wainwright
Atai Life Sciences price target lowered to $20 from $50 at H.C. Wainwright
01/09/23 Canaccord
Atai Life Sciences price target lowered to $11 from $27 at Canaccord
01/09/23 Loop Capital
Atai Life Sciences price target lowered to $10 from $18 at Loop Capital
01/09/23 Citi
Atai Life Sciences price target lowered to $10 from $20 at Citi
CMPS Compass Pathways
$10.74 /

+0.1 (+0.94%)

12/15/22 EF Hutton
Compass Pathways initiated with a Buy at EF Hutton
12/09/22 Oppenheimer
Compass Pathways price target lowered to $33 from $55 at Oppenheimer
11/01/22 Loop Capital
Compass Pathways initiated with a Buy at Loop Capital
RLMD Relmada Therapeutics
$4.31 /

+0.05 (+1.17%)

12/08/22 Truist
Relmada Therapeutics price target lowered to $4 from $7 at Truist
11/11/22 SVB Securities
Relmada 'still has a chance' for positive depression data, says SVB
10/14/22 BofA
Axsome shares could react positively to Relmada trial failure, says BofA
10/14/22 Goldman Sachs
Relmada Therapeutics downgraded to Neutral from Buy at Goldman Sachs
ZYNE Zynerba
/

+

TLRY Tilray
$3.50 /

+0.16 (+4.80%)

RLMD Relmada Therapeutics
$4.31 /

+0.05 (+1.17%)

INCR InterCure
$3.81 /

+0.11 (+2.97%)

HITI High Tide
$1.60 /

+0.04 (+2.56%)

GNLN Greenlane
/

+

FLGC Flora Growth
/

+

CRON Cronos Group
$2.59 /

+0.065 (+2.58%)

CMPS Compass Pathways
$10.74 /

+0.1 (+0.94%)

CGC Canopy Growth
$3.15 /

+0.08 (+2.61%)

AYRWF Ayr Wellness
$1.34 /

+0.059 (+4.61%)

ATAI Atai Life Sciences
$1.90 /

+0.05 (+2.70%)

ACB Aurora Cannabis
$1.14 /

+0.055 (+5.07%)

  • 27
    May
IGC India Globalization Capital
/

+

ATAI Atai Life Sciences
$1.90 /

+0.05 (+2.70%)

INCR InterCure
$3.81 /

+0.11 (+2.97%)

IGC India Globalization Capital
/

+

HITI High Tide
$1.60 /

+0.04 (+2.56%)

FLGC Flora Growth
/

+

AYRWF Ayr Wellness
$1.34 /

+0.059 (+4.61%)

ATAI Atai Life Sciences
$1.90 /

+0.05 (+2.70%)

TLRY Tilray
$3.50 /

+0.16 (+4.80%)

RLMD Relmada Therapeutics
$4.31 /

+0.05 (+1.17%)

INCR InterCure
$3.81 /

+0.11 (+2.97%)

CGC Canopy Growth
$3.15 /

+0.08 (+2.61%)

ACB Aurora Cannabis
$1.14 /

+0.055 (+5.07%)

Over a week ago
Recommendations
Canopy Growth price target lowered to C$2.50 from C$3 at CIBC » 11:37
02/01/23
02/01
11:37
02/01/23
11:37
CGC

Canopy Growth

$2.99 /

-0.035 (-1.16%)

CIBC analyst John Zamparo…

CIBC analyst John Zamparo lowered the firm's price target on Canopy Growth to C$2.50 from C$3 and keeps an Underperformer rating on the shares.

ShowHide Related Items >><<
CGC Canopy Growth
$2.99 /

-0.035 (-1.16%)

CGC Canopy Growth
$2.99 /

-0.035 (-1.16%)

11/09/22 Bernstein
Two more states legalize cannabis, $3B added to TAM, says Bernstein
11/07/22 Canaccord
Canopy Growth price target raised to C$5 from C$4.25 at Canaccord
11/01/22 Bernstein
Bernstein starts Canopy Growth at Underperform, sees equity raise
11/01/22 Bernstein
Canopy Growth initiated with an Underperform at Bernstein
CGC Canopy Growth
$2.99 /

-0.035 (-1.16%)

CGC Canopy Growth
$2.99 /

-0.035 (-1.16%)

CGC Canopy Growth
$2.99 /

-0.035 (-1.16%)

CGC Canopy Growth
$2.99 /

-0.035 (-1.16%)

Options
Largest borrow rate increases among liquid names » 08:45
01/31/23
01/31
08:45
01/31/23
08:45
GOEV

Canoo

$1.23 /

-0.145 (-10.55%)

, DMTK

DermTech

$5.45 /

-0.74 (-11.95%)

, LCID

Lucid Group

$11.75 /

-1.16 (-8.99%)

, SLG

SL Green Realty

$39.29 /

+0.0958 (+0.24%)

, SJT

San Juan Basin Royalty Trust

$10.18 /

-0.4678 (-4.39%)

, MARA

Marathon Digital

$7.15 /

-0.855 (-10.68%)

, RUM

Rumble

$9.97 /

+0.02 (+0.20%)

, SOLO

ElectraMeccanica

/

+

, CGC

Canopy Growth

$2.84 /

-0.09 (-3.08%)

, BLNK

Blink Charging

$13.30 /

-0.83 (-5.87%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: Canoo (GOEV) 61.33% +17.13, DermTech (DMTK) 26.46% +10.59, Lucid Group (LCID) 62.10% +1.72, SL Green Realty (SLG) 1.64% +1.02, San Juan Basin Royalty Trust (SJT) 13.71% +0.49, Marathon Patent Group (MARA) 120.10% +0.45, Rumble (RUM) 95.03% +0.30, Electrameccanica Vehicles Corp (SOLO) 50.98% +0.27, Canopy Growth (CGC) 86.82% +0.25, and Blink Charging (BLNK) 25.24% +0.21.

ShowHide Related Items >><<
SOLO ElectraMeccanica
/

+

SLG SL Green Realty
$39.29 /

+0.0958 (+0.24%)

RUM Rumble
$9.97 /

+0.02 (+0.20%)

MARA Marathon Digital
$7.15 /

-0.855 (-10.68%)

LCID Lucid Group
$11.75 /

-1.16 (-8.99%)

GOEV Canoo
$1.23 /

-0.145 (-10.55%)

CGC Canopy Growth
$2.84 /

-0.09 (-3.08%)

BLNK Blink Charging
$13.30 /

-0.83 (-5.87%)

GOEV Canoo
$1.23 /

-0.145 (-10.55%)

11/10/22 R.F. Lafferty
Canoo price target lowered to $6 from $15 at R.F. Lafferty
09/15/22 Stifel
Canoo initiated with a Buy at Stifel
08/09/22 Roth MKM
Canoo downgraded to Neutral at Roth Capital on increased need for cash
08/09/22 Roth MKM
Canoo downgraded to Neutral from Buy at Roth Capital
DMTK DermTech
$5.45 /

-0.74 (-11.95%)

11/08/22 BTIG
DermTech price target lowered to $6 from $15 at BTIG
11/07/22 Cowen
DermTech price target lowered to $8 from $20 at Cowen
11/04/22 Lake Street
DermTech price target lowered to $6 from $14 at Lake Street
11/04/22 William Blair
William Blair downgrades DermTech on commercial payer headwinds
LCID Lucid Group
$11.75 /

-1.16 (-8.99%)

01/25/23 Morgan Stanley
Lucid Group price target lowered to $5 from $10 at Morgan Stanley
01/22/23 Citi
Lucid Group resumed with a Buy at Citi
01/12/23 Cantor Fitzgerald
Lucid's Q4 production pre-announcement 'encouraging, says Cantor Fitzgerald
01/12/23 Evercore ISI
Evercore ISI says Lucid FY/Q4 production serves as glimmer of execution progress
SLG SL Green Realty
$39.29 /

+0.0958 (+0.24%)

01/30/23 Baird
SL Green Realty price target raised to $43 from $38 at Baird
01/04/23 Deutsche Bank
Deutsche downgrades six REITs to Hold, urges caution into 2023
01/04/23 Mizuho
SL Green Realty price target lowered to $38 from $48 at Mizuho
01/04/23 Deutsche Bank
SL Green Realty downgraded to Hold from Buy at Deutsche Bank
SJT San Juan Basin Royalty Trust
$10.18 /

-0.4678 (-4.39%)

MARA Marathon Digital
$7.15 /

-0.855 (-10.68%)

01/12/23 DA Davidson
Marathon Digital price target lowered to $12 from $18 at DA Davidson
01/09/23 Jefferies
Marathon Digital downgraded to Hold from Buy at Jefferies
11/08/22 Jefferies
Marathon Digital price target lowered to $12.50 from $24 at Jefferies
10/25/22 Compass Point
Marathon Digital price target lowered to $21 from $30 at Compass Point
RUM Rumble
$9.97 /

+0.02 (+0.20%)

12/02/22 Oppenheimer
Rumble initiated with a Perform at Oppenheimer
SOLO ElectraMeccanica
/

+

CGC Canopy Growth
$2.84 /

-0.09 (-3.08%)

11/09/22 Bernstein
Two more states legalize cannabis, $3B added to TAM, says Bernstein
11/07/22 Canaccord
Canopy Growth price target raised to C$5 from C$4.25 at Canaccord
11/01/22 Bernstein
Bernstein starts Canopy Growth at Underperform, sees equity raise
11/01/22 Bernstein
Canopy Growth initiated with an Underperform at Bernstein
BLNK Blink Charging
$13.30 /

-0.83 (-5.87%)

11/07/22 B. Riley
Blink Charging price target lowered to $14 from $15 at B. Riley
08/16/22 Stifel
Blink Charging price target raised to $23 from $19 at Stifel
06/22/22 Stifel
Blink Charging price target lowered to $19 from $30 at Stifel
06/17/22 B. Riley
B. Riley sees challenges for Blink Charging, starts with Neutral
SOLO ElectraMeccanica
/

+

SLG SL Green Realty
$39.29 /

+0.0958 (+0.24%)

MARA Marathon Digital
$7.15 /

-0.855 (-10.68%)

LCID Lucid Group
$11.75 /

-1.16 (-8.99%)

GOEV Canoo
$1.23 /

-0.145 (-10.55%)

DMTK DermTech
$5.45 /

-0.74 (-11.95%)

CGC Canopy Growth
$2.84 /

-0.09 (-3.08%)

BLNK Blink Charging
$13.30 /

-0.83 (-5.87%)

RUM Rumble
$9.97 /

+0.02 (+0.20%)

MARA Marathon Digital
$7.15 /

-0.855 (-10.68%)

LCID Lucid Group
$11.75 /

-1.16 (-8.99%)

GOEV Canoo
$1.23 /

-0.145 (-10.55%)

CGC Canopy Growth
$2.84 /

-0.09 (-3.08%)

SLG SL Green Realty
$39.29 /

+0.0958 (+0.24%)

RUM Rumble
$9.97 /

+0.02 (+0.20%)

MARA Marathon Digital
$7.15 /

-0.855 (-10.68%)

LCID Lucid Group
$11.75 /

-1.16 (-8.99%)

GOEV Canoo
$1.23 /

-0.145 (-10.55%)

DMTK DermTech
$5.45 /

-0.74 (-11.95%)

CGC Canopy Growth
$2.84 /

-0.09 (-3.08%)

SOLO ElectraMeccanica
/

+

SLG SL Green Realty
$39.29 /

+0.0958 (+0.24%)

SJT San Juan Basin Royalty Trust
$10.18 /

-0.4678 (-4.39%)

RUM Rumble
$9.97 /

+0.02 (+0.20%)

MARA Marathon Digital
$7.15 /

-0.855 (-10.68%)

LCID Lucid Group
$11.75 /

-1.16 (-8.99%)

GOEV Canoo
$1.23 /

-0.145 (-10.55%)

CGC Canopy Growth
$2.84 /

-0.09 (-3.08%)

BLNK Blink Charging
$13.30 /

-0.83 (-5.87%)

Hot Stocks
Charlotte's Web 'encouraged' after FDA statement, agrees on testing's importance » 14:49
01/27/23
01/27
14:49
01/27/23
14:49
CWBHF

Charlotte's Web

/

+

Charlotte's Web…

Charlotte's Web issued the following statement regarding the FDA's January 26th press announcement: "Charlotte's Web is encouraged that the Administration has agreed that it is necessary for Congress to act for the regulation of hemp-derived cannabidiol, or 'CBD.' The FDA position has taken four years to come together, while the CBD industry has matured without a clear regulatory pathway for CBD products that are already available for sale in all 50 states and consumed safely by millions of Americans. This includes professional athletes, veterans, and everyday wellness seekers. The company looks forward to continuing its work in Washington DC to forward this process. The company also agrees with the FDA on the importance of testing to ensure the quality and safety of CBD products and has already provided studies to support this position. As the CBD pioneer and market leader, Charlotte's Web has engaged in safety studies and compiled toxicology data including liver safety. These studies have been conducted under an Institutional Review Board and Good Laboratory Practices, following guidelines of the Organization for Economic Co-operation and Development. They have been subjected to an unbiased peer review and published in journals and have been vetted and accepted for indexing in the PubMed central database. These studies support the efforts of a legislative regulatory framework. During this four-year period of regulatory absence, Charlotte's Web has set the standard in responsible self-regulation in product manufacturing, safety, and labeling. In addition to safety and toxicology studies the Company utilizes cGMP-compliant manufacturing facilities, seed-to-shelf testing, and certificate of analysis transparency for all products. Recently, Charlotte's Web became the first and only broad-spectrum CBD hemp extract to be NSF Certified for Sport, the gold standard to ensure safe and consistent products for professional athletes and consumers alike."

ShowHide Related Items >><<
CWBHF Charlotte's Web
/

+

CWBHF Charlotte's Web
/

+

08/10/22 Canaccord
Charlotte's Web price target lowered to C$2 from C$2.25 at Canaccord
05/20/22 Cowen
Charlotte's Web price target lowered to $1 from $2 at Cowen
05/18/22 Canaccord
Charlotte's Web price target lowered to C$2.25 from C$3 at Canaccord
05/18/22 Benchmark
Charlotte's Web downgraded to Hold from Speculative Buy at Benchmark
Options
Largest borrow rate increases among liquid names » 08:45
01/27/23
01/27
08:45
01/27/23
08:45
CGC

Canopy Growth

$2.76 /

-0.005 (-0.18%)

, INDA

iShares MSCI India ETF

$41.91 /

+0.135 (+0.32%)

, XBI

SPDR S&P BIOTECH

$88.59 /

-0.29 (-0.33%)

, GFS

GlobalFoundries

$60.10 /

+1.4 (+2.39%)

, FRO

Frontline

$13.38 /

-0.025 (-0.19%)

, BWEN

Broadwind

$5.25 /

-0.11 (-2.05%)

, DNN

Denison Mines

$1.43 /

-0.015 (-1.04%)

, THC

Tenet Healthcare

$51.67 /

+1.12 (+2.22%)

, MSFT

Microsoft

$248.11 /

+7.68 (+3.19%)

, DUST

Direxion Daily Gold Miners Bear 3X ETF

$11.03 /

+0.305 (+2.84%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: Canopy Growth (CGC) 87.09% +2.11, iShares MSCI India (INDA) 2.74% +2.07, SPDR S&P Biotech (XBI) 3.90% +0.70, Globalfoundries (GFS) 5.09% +0.49, Frontline (FRO) 3.23% +0.48, Broadwind Energy (BWEN) 12.71% +0.41, Denison Mines (DNN) 4.41% +0.26, Tenet (THC) 0.41% +0.15, Microsoft (MSFT) 0.41% +0.14, and Gold Bear 3x (DUST) 12.29% +0.13.

ShowHide Related Items >><<
THC Tenet Healthcare
$51.67 /

+1.12 (+2.22%)

MSFT Microsoft
$248.11 /

+7.68 (+3.19%)

GFS GlobalFoundries
$60.10 /

+1.4 (+2.39%)

FRO Frontline
$13.38 /

-0.025 (-0.19%)

DUST Direxion Daily Gold Miners Bear 3X ETF
$11.03 /

+0.305 (+2.84%)

DNN Denison Mines
$1.43 /

-0.015 (-1.04%)

CGC Canopy Growth
$2.76 /

-0.005 (-0.18%)

BWEN Broadwind
$5.25 /

-0.11 (-2.05%)

CGC Canopy Growth
$2.76 /

-0.005 (-0.18%)

11/09/22 Bernstein
Two more states legalize cannabis, $3B added to TAM, says Bernstein
11/07/22 Canaccord
Canopy Growth price target raised to C$5 from C$4.25 at Canaccord
11/01/22 Bernstein
Bernstein starts Canopy Growth at Underperform, sees equity raise
11/01/22 Bernstein
Canopy Growth initiated with an Underperform at Bernstein
INDA iShares MSCI India ETF
$41.91 /

+0.135 (+0.32%)

XBI SPDR S&P BIOTECH
$88.59 /

-0.29 (-0.33%)

GFS GlobalFoundries
$60.10 /

+1.4 (+2.39%)

01/23/23 Loop Capital
GlobalFoundries initiated with a Buy at Loop Capital
12/14/22 Deutsche Bank
GlobalFoundries price target raised to $70 from $67 at Deutsche Bank
11/15/22 Credit Suisse
GlobalFoundries assumed with an Outperform at Credit Suisse
11/09/22 BofA
GlobalFoundries price target raised to $80 from $75 at BofA
FRO Frontline
$13.38 /

-0.025 (-0.19%)

01/12/23 Deutsche Bank
Frontline price target raised to $16.50 from $15 at Deutsche Bank
01/11/23 JonesResearch
Euronav NV upgraded to Buy from Hold at JonesResearch
01/10/23 Stifel
Euronav NV downgraded to Hold from Buy at Stifel
11/29/22 Jefferies
Frontline price target raised to $17 from $16 at Jefferies
BWEN Broadwind
$5.25 /

-0.11 (-2.05%)

01/17/23 H.C. Wainwright
Broadwind upgraded to Buy from Neutral at H.C. Wainwright
01/12/23 Craig-Hallum
Broadwind price target raised to $9 from $4 at Craig-Hallum
DNN Denison Mines
$1.43 /

-0.015 (-1.04%)

08/24/22 TD Securities
Denison Mines resumed with a Speculative Buy at TD Securities
05/27/22 TD Securities
Denison Mines upgraded to Speculative Buy from Hold at TD Securities
THC Tenet Healthcare
$51.67 /

+1.12 (+2.22%)

01/03/23 Truist
Tenet Healthcare price target raised to $60 from $55 at Truist
12/06/22 Loop Capital
Tenet Healthcare price target raised to $45 from $40 at Loop Capital
10/27/22 Raymond James
Tenet Healthcare price target lowered to $80 from $135 at Raymond James
10/25/22 Citi
Tenet Healthcare shares offer 'significant upside,' says Citi
MSFT Microsoft
$248.11 /

+7.68 (+3.19%)

01/27/23 Wedbush
Activision Blizzard assumed with an Outperform at Wedbush
01/26/23 Credit Suisse
Microsoft price target lowered to $285 from $365 at Credit Suisse
01/26/23 Oppenheimer
Alphabet price target lowered to $130 from $135 at Oppenheimer
01/25/23 Oppenheimer
Microsoft results better than feared, macro trends weakening, says Oppenheimer
DUST Direxion Daily Gold Miners Bear 3X ETF
$11.03 /

+0.305 (+2.84%)

THC Tenet Healthcare
$51.67 /

+1.12 (+2.22%)

MSFT Microsoft
$248.11 /

+7.68 (+3.19%)

GFS GlobalFoundries
$60.10 /

+1.4 (+2.39%)

FRO Frontline
$13.38 /

-0.025 (-0.19%)

CGC Canopy Growth
$2.76 /

-0.005 (-0.18%)

BWEN Broadwind
$5.25 /

-0.11 (-2.05%)

THC Tenet Healthcare
$51.67 /

+1.12 (+2.22%)

MSFT Microsoft
$248.11 /

+7.68 (+3.19%)

GFS GlobalFoundries
$60.10 /

+1.4 (+2.39%)

CGC Canopy Growth
$2.76 /

-0.005 (-0.18%)

THC Tenet Healthcare
$51.67 /

+1.12 (+2.22%)

MSFT Microsoft
$248.11 /

+7.68 (+3.19%)

GFS GlobalFoundries
$60.10 /

+1.4 (+2.39%)

FRO Frontline
$13.38 /

-0.025 (-0.19%)

DNN Denison Mines
$1.43 /

-0.015 (-1.04%)

CGC Canopy Growth
$2.76 /

-0.005 (-0.18%)

THC Tenet Healthcare
$51.67 /

+1.12 (+2.22%)

MSFT Microsoft
$248.11 /

+7.68 (+3.19%)

INDA iShares MSCI India ETF
$41.91 /

+0.135 (+0.32%)

FRO Frontline
$13.38 /

-0.025 (-0.19%)

DUST Direxion Daily Gold Miners Bear 3X ETF
$11.03 /

+0.305 (+2.84%)

DNN Denison Mines
$1.43 /

-0.015 (-1.04%)

CGC Canopy Growth
$2.76 /

-0.005 (-0.18%)

On The Fly
Here's What You Missed in Cannabis, Psychedelics This Week » 11:38
01/26/23
01/26
11:38
01/26/23
11:38
AVTBF

Avant Brands

/

+

, BMMJ

Body and Mind

/

+

, LOVFF

Cannara Biotech

/

+

, CLVR

Clever Leaves

/

+

, CURLF

Curaleaf

$3.61 /

-0.2276 (-5.93%)

, DMTTF

Small Pharma

/

+

, IIPR

Innovative Industrial Properties

$85.74 /

-0.64 (-0.74%)

, ACB

Aurora Cannabis

/

+

, CVSI

CV Sciences

/

+

, CTST

CannTrust

/

+

, CGC

Canopy Growth

$2.72 /

-0.045 (-1.63%)

, CRON

Cronos Group

$2.41 /

-0.04 (-1.63%)

, GDNSF

Goodness Growth

/

+

, GTBIF

Green Thumb Industries

$7.81 /

-0.08 (-1.01%)

, TLRY

Tilray

$3.04 /

-0.055 (-1.78%)

, CANN

Trees Corporation

/

+

, TCNNF

Trulieve Cannabis

$6.31 /

-0.35 (-5.26%)

, ZYNE

Zynerba

/

+

, ATAI

Atai Life Sciences

$1.85 /

-0.015 (-0.80%)

, RLMD

Relmada Therapeutics

$4.31 /

-0.06 (-1.37%)

, CMPS

Compass Pathways

$10.73 /

+0.12 (+1.13%)

, IGC

India Globalization Capital

/

+

In this week's "Rising…

ShowHide Related Items >><<
ZYNE Zynerba
/

+

TLRY Tilray
$3.04 /

-0.055 (-1.78%)

TCNNF Trulieve Cannabis
$6.31 /

-0.35 (-5.26%)

RLMD Relmada Therapeutics
$4.31 /

-0.06 (-1.37%)

IIPR Innovative Industrial Properties
$85.74 /

-0.64 (-0.74%)

IGC India Globalization Capital
/

+

GTBIF Green Thumb Industries
$7.81 /

-0.08 (-1.01%)

GDNSF Goodness Growth
/

+

DMTTF Small Pharma
/

+

CVSI CV Sciences
/

+

CURLF Curaleaf
$3.61 /

-0.2276 (-5.93%)

CRON Cronos Group
$2.41 /

-0.04 (-1.63%)

CMPS Compass Pathways
$10.73 /

+0.12 (+1.13%)

CLVR Clever Leaves
/

+

CGC Canopy Growth
$2.72 /

-0.045 (-1.63%)

CANN Trees Corporation
/

+

AVTBF Avant Brands
/

+

ATAI Atai Life Sciences
$1.85 /

-0.015 (-0.80%)

ACB Aurora Cannabis
/

+

AVTBF Avant Brands
/

+

BMMJ Body and Mind
/

+

LOVFF Cannara Biotech
/

+

CLVR Clever Leaves
/

+

11/11/22 Canaccord
Clever Leaves downgraded to Hold at Canaccord on slow growth
11/11/22 Canaccord
Clever Leaves downgraded to Hold from Buy at Canaccord
08/01/22 Cantor Fitzgerald
Cantor starts Clever Leaves at Overweight for overseas medical cannabis exposure
08/01/22 Cantor Fitzgerald
Clever Leaves initiated with an Overweight at Cantor Fitzgerald
CURLF Curaleaf
$3.61 /

-0.2276 (-5.93%)

12/30/22 Cantor Fitzgerald
Curaleaf price target lowered to $12 from $13 at Cantor Fitzgerald
12/01/22 Wedbush
Wedbush starts Curaleaf with Outperform, expects share gains
12/01/22 Wedbush
Curaleaf initiated with an Outperform at Wedbush
11/08/22 Stifel
Curaleaf price target lowered to C$8.50 from C$9.50 at Stifel
DMTTF Small Pharma
/

+

12/15/22 EF Hutton
Small Pharma initiated with a Buy at EF Hutton
10/18/22 Canaccord
Small Pharma price target lowered to C$0.75 from C$1 at Canaccord
IIPR Innovative Industrial Properties
$85.74 /

-0.64 (-0.74%)

01/24/23 BTIG
Innovative Industrial Properties price target lowered to $179 from $196 at BTIG
01/20/23 JMP Securities
Innovative Industrial Properties downgraded to Market Perform at JMP Securities
01/03/23 BTIG
WeWork named Top Pick for first half of 2023 at BTIG
11/09/22 Roth MKM
Innovative Industrial Properties price target lowered to $170 from $190 at Roth Capital
ACB Aurora Cannabis
/

+

12/28/22 Piper Sandler
Aurora Cannabis price target lowered to $1 from $2 at Piper Sandler
11/09/22 Bernstein
Two more states legalize cannabis, $3B added to TAM, says Bernstein
10/07/22 Stifel
Cannabis stocks could rise about three times in near-term, says Stifel
09/21/22 Canaccord
Aurora Cannabis upgraded to Hold from Sell at Canaccord
CVSI CV Sciences
/

+

04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
CTST CannTrust
/

+

CGC Canopy Growth
$2.72 /

-0.045 (-1.63%)

11/07/22 Canaccord
Canopy Growth price target raised to C$5 from C$4.25 at Canaccord
11/01/22 Bernstein
Bernstein starts Canopy Growth at Underperform, sees equity raise
11/01/22 Bernstein
Canopy Growth initiated with an Underperform at Bernstein
CRON Cronos Group
$2.41 /

-0.04 (-1.63%)

11/08/22 Canaccord
Cronos Group price target lowered to C$4.75 from C$5 at Canaccord
11/01/22 Bernstein
Cronos started with Market Perform on limited visibility at Bernstein
11/01/22 Bernstein
Cronos Group initiated with a Market Perform at Bernstein
GDNSF Goodness Growth
/

+

11/16/22 Canaccord
Goodness Growth price target lowered to C$0.85 from C$1 at Canaccord
10/14/22 Alliance Global Partners
Verano Holdings price target lowered to C$12 from C$16 at Alliance Global
05/12/22 Canaccord
Goodness Growth price target lowered to C$3.50 from C$4 at Canaccord
GTBIF Green Thumb Industries
$7.81 /

-0.08 (-1.01%)

12/01/22 Wedbush
Wedbush starts Green Thumb with Outperform, names top cannabis pick
12/01/22 Wedbush
Green Thumb Industries initiated with an Outperform at Wedbush
11/03/22 Stifel
Green Thumb Industries price target raised to C$31 from C$30.50 at Stifel
TLRY Tilray
$3.04 /

-0.055 (-1.78%)

01/10/23 MKM Partners
Tilray price target lowered to $3 from $4 at MKM Partners
01/10/23 Canaccord
Tilray price target lowered to $5 from $7 at Canaccord
01/09/23 Alliance Global Partners
Tilray price target lowered to $3 from $4 at Alliance Global Partners
12/28/22 Piper Sandler
Tilray estimates lowered on softer beer sales at Piper Sandler
CANN Trees Corporation
/

+

TCNNF Trulieve Cannabis
$6.31 /

-0.35 (-5.26%)

12/01/22 Wedbush
Wedbush starts Trulieve with Outperform on broadening reach
12/01/22 Wedbush
Trulieve Cannabis initiated with an Outperform at Wedbush
11/10/22 Canaccord
Trulieve Cannabis price target lowered to C$50 from C$54 at Canaccord
ZYNE Zynerba
/

+

06/23/22 Canaccord
Zynerba price target raised to $11 from $9 at Canaccord
ATAI Atai Life Sciences
$1.85 /

-0.015 (-0.80%)

01/19/23 H.C. Wainwright
Atai Life Sciences price target lowered to $20 from $50 at H.C. Wainwright
01/09/23 Canaccord
Atai Life Sciences price target lowered to $11 from $27 at Canaccord
01/09/23 Loop Capital
Atai Life Sciences price target lowered to $10 from $18 at Loop Capital
01/09/23 Citi
Atai Life Sciences price target lowered to $10 from $20 at Citi
RLMD Relmada Therapeutics
$4.31 /

-0.06 (-1.37%)

12/08/22 Truist
Relmada Therapeutics price target lowered to $4 from $7 at Truist
11/11/22 SVB Securities
Relmada 'still has a chance' for positive depression data, says SVB
10/14/22 BofA
Axsome shares could react positively to Relmada trial failure, says BofA
10/14/22 Goldman Sachs
Relmada Therapeutics downgraded to Neutral from Buy at Goldman Sachs
CMPS Compass Pathways
$10.73 /

+0.12 (+1.13%)

12/15/22 EF Hutton
Compass Pathways initiated with a Buy at EF Hutton
12/09/22 Oppenheimer
Compass Pathways price target lowered to $33 from $55 at Oppenheimer
11/01/22 Loop Capital
Compass Pathways initiated with a Buy at Loop Capital
IGC India Globalization Capital
/

+

ZYNE Zynerba
/

+

TLRY Tilray
$3.04 /

-0.055 (-1.78%)

RLMD Relmada Therapeutics
$4.31 /

-0.06 (-1.37%)

IIPR Innovative Industrial Properties
$85.74 /

-0.64 (-0.74%)

CURLF Curaleaf
$3.61 /

-0.2276 (-5.93%)

CRON Cronos Group
$2.41 /

-0.04 (-1.63%)

CMPS Compass Pathways
$10.73 /

+0.12 (+1.13%)

CLVR Clever Leaves
/

+

CGC Canopy Growth
$2.72 /

-0.045 (-1.63%)

ATAI Atai Life Sciences
$1.85 /

-0.015 (-0.80%)

ACB Aurora Cannabis
/

+

  • 27
    May
  • 01
    Apr
ATAI Atai Life Sciences
$1.85 /

-0.015 (-0.80%)

ACB Aurora Cannabis
/

+

LOVFF Cannara Biotech
/

+

IIPR Innovative Industrial Properties
$85.74 /

-0.64 (-0.74%)

CURLF Curaleaf
$3.61 /

-0.2276 (-5.93%)

CLVR Clever Leaves
/

+

AVTBF Avant Brands
/

+

ATAI Atai Life Sciences
$1.85 /

-0.015 (-0.80%)

ACB Aurora Cannabis
/

+

TLRY Tilray
$3.04 /

-0.055 (-1.78%)

RLMD Relmada Therapeutics
$4.31 /

-0.06 (-1.37%)

IIPR Innovative Industrial Properties
$85.74 /

-0.64 (-0.74%)

CGC Canopy Growth
$2.72 /

-0.045 (-1.63%)

ACB Aurora Cannabis
/

+

Hot Stocks
Curaleaf closes operations in California, Colorado and Oregon, cuts payroll 10% » 08:04
01/26/23
01/26
08:04
01/26/23
08:04
CURLF

Curaleaf

$3.61 /

-0.2276 (-5.93%)

Curaleaf announced the…

Curaleaf announced the proactive closure of the majority of its operations in California, Colorado and Oregon, beginning this month, as part of its continued effort to streamline its business. Additionally, in an effort to further optimize operations and reduce costs, the company will consolidate cultivation and processing operations in Massachusetts to a single facility in Webster, resulting in the closure of its Amesbury facility. Curaleaf expects to record non-cash restructuring and impairment charges that it will detail on its fourth quarter earnings call in March. Concurrent with these actions, the company has reduced its payroll by 10% which, when coupled with other cost savings initiatives, it expects to realize $60M in gross run-rate expense savings in 2023, exceeding its initial savings target by 50%. The company will exit production and cultivation facilities in California, Colorado and Oregon. While these states have contributed to the growth of Select and other Curaleaf wholesale brands, the company acknowledges the difficult operating environment in these investment states and will instead place a laser focus on cash generation in its core revenue-driving markets moving forward. Curaleaf began aggressive cost-cutting measures in these states in 2022 through facility closures and reductions in workforce. These adjustments were necessary for the future success and profitability of the business and were made as a result of recent legislative decisions, price compression, and lack of enforcement of the illicit market. For context, these markets contributed less than $50M in revenue to Curaleaf last year. Curaleaf expects these market closures will be immediately accretive to its adjusted EBITDA margins and positions it for robust positive free cash flow generation in excess of $125M this year as management executes on its strategic priorities.

ShowHide Related Items >><<
CURLF Curaleaf
$3.61 /

-0.2276 (-5.93%)

CURLF Curaleaf
$3.61 /

-0.2276 (-5.93%)

12/30/22 Cantor Fitzgerald
Curaleaf price target lowered to $12 from $13 at Cantor Fitzgerald
12/01/22 Wedbush
Wedbush starts Curaleaf with Outperform, expects share gains
12/01/22 Wedbush
Curaleaf initiated with an Outperform at Wedbush
11/08/22 Stifel
Curaleaf price target lowered to C$8.50 from C$9.50 at Stifel
CURLF Curaleaf
$3.61 /

-0.2276 (-5.93%)

CURLF Curaleaf
$3.61 /

-0.2276 (-5.93%)

Hot Stocks
Curaleaf expands Grassroots premium cannabis brand to New Jersey » 08:12
01/24/23
01/24
08:12
01/24/23
08:12
CURLF

Curaleaf

$3.96 /

-0.1 (-2.46%)

Curaleaf announced the…

Curaleaf announced the expansion of its Grassroots brand in New Jersey with the launch of premium cannabis flower and pre-rolls. Available now at all Curaleaf locations across the state, New Jersey is the eighth market to offer Grassroots' carefully cultivated products following its strategic national rebrand in November 2022.

ShowHide Related Items >><<
CURLF Curaleaf
$3.96 /

-0.1 (-2.46%)

CURLF Curaleaf
$3.96 /

-0.1 (-2.46%)

12/30/22 Cantor Fitzgerald
Curaleaf price target lowered to $12 from $13 at Cantor Fitzgerald
12/01/22 Wedbush
Wedbush starts Curaleaf with Outperform, expects share gains
12/01/22 Wedbush
Curaleaf initiated with an Outperform at Wedbush
11/08/22 Stifel
Curaleaf price target lowered to C$8.50 from C$9.50 at Stifel
CURLF Curaleaf
$3.96 /

-0.1 (-2.46%)

CURLF Curaleaf
$3.96 /

-0.1 (-2.46%)

On The Fly
Rising High: Exclusive talk with biotech company Tryp Therapeutics » 11:26
01/19/23
01/19
11:26
01/19/23
11:26
TRYPF

Tryp Therapeutics

/

+

, ATAI

Atai Life Sciences

$1.94 /

-0.065 (-3.24%)

, RLMD

Relmada Therapeutics

$4.42 /

+0.135 (+3.15%)

, CMPS

Compass Pathways

$9.75 /

-0.26 (-2.60%)

, ACB

Aurora Cannabis

/

+

, CVSI

CV Sciences

/

+

, CTST

CannTrust

/

+

, CGC

Canopy Growth

$2.61 /

-0.055 (-2.07%)

, CRON

Cronos Group

$2.43 /

-0.05 (-2.02%)

, GDNSF

Goodness Growth

/

+

, GTBIF

Green Thumb Industries

$8.38 /

-0.12 (-1.41%)

, IGC

India Globalization Capital

/

+

, TLRY

Tilray

$2.94 /

-0.12 (-3.92%)

, CANN

Trees Corporation

/

+

, TCNNF

Trulieve Cannabis

$7.05 /

-0.194 (-2.68%)

, ZYNE

Zynerba

/

+

In this edition of…

ShowHide Related Items >><<
ZYNE Zynerba
/

+

TRYPF Tryp Therapeutics
/

+

TLRY Tilray
$2.94 /

-0.12 (-3.92%)

TCNNF Trulieve Cannabis
$7.05 /

-0.194 (-2.68%)

RLMD Relmada Therapeutics
$4.42 /

+0.135 (+3.15%)

IGC India Globalization Capital
/

+

GTBIF Green Thumb Industries
$8.38 /

-0.12 (-1.41%)

GDNSF Goodness Growth
/

+

CVSI CV Sciences
/

+

CRON Cronos Group
$2.43 /

-0.05 (-2.02%)

CMPS Compass Pathways
$9.75 /

-0.26 (-2.60%)

CGC Canopy Growth
$2.61 /

-0.055 (-2.07%)

CANN Trees Corporation
/

+

ATAI Atai Life Sciences
$1.94 /

-0.065 (-3.24%)

ACB Aurora Cannabis
/

+

TRYPF Tryp Therapeutics
/

+

ATAI Atai Life Sciences
$1.94 /

-0.065 (-3.24%)

01/19/23 H.C. Wainwright
Atai Life Sciences price target lowered to $20 from $50 at H.C. Wainwright
01/09/23 Canaccord
Atai Life Sciences price target lowered to $11 from $27 at Canaccord
01/09/23 Loop Capital
Atai Life Sciences price target lowered to $10 from $18 at Loop Capital
01/09/23 Citi
Atai Life Sciences price target lowered to $10 from $20 at Citi
RLMD Relmada Therapeutics
$4.42 /

+0.135 (+3.15%)

12/08/22 Truist
Relmada Therapeutics price target lowered to $4 from $7 at Truist
11/11/22 SVB Securities
Relmada 'still has a chance' for positive depression data, says SVB
10/14/22 BofA
Axsome shares could react positively to Relmada trial failure, says BofA
10/14/22 Goldman Sachs
Relmada Therapeutics downgraded to Neutral from Buy at Goldman Sachs
CMPS Compass Pathways
$9.75 /

-0.26 (-2.60%)

12/15/22 EF Hutton
Compass Pathways initiated with a Buy at EF Hutton
12/09/22 Oppenheimer
Compass Pathways price target lowered to $33 from $55 at Oppenheimer
11/01/22 Loop Capital
Compass Pathways initiated with a Buy at Loop Capital
ACB Aurora Cannabis
/

+

12/28/22 Piper Sandler
Aurora Cannabis price target lowered to $1 from $2 at Piper Sandler
11/09/22 Bernstein
Two more states legalize cannabis, $3B added to TAM, says Bernstein
10/07/22 Stifel
Cannabis stocks could rise about three times in near-term, says Stifel
09/21/22 Canaccord
Aurora Cannabis upgraded to Hold from Sell at Canaccord
CVSI CV Sciences
/

+

04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
CTST CannTrust
/

+

CGC Canopy Growth
$2.61 /

-0.055 (-2.07%)

11/07/22 Canaccord
Canopy Growth price target raised to C$5 from C$4.25 at Canaccord
11/01/22 Bernstein
Bernstein starts Canopy Growth at Underperform, sees equity raise
11/01/22 Bernstein
Canopy Growth initiated with an Underperform at Bernstein
CRON Cronos Group
$2.43 /

-0.05 (-2.02%)

11/08/22 Canaccord
Cronos Group price target lowered to C$4.75 from C$5 at Canaccord
11/01/22 Bernstein
Cronos started with Market Perform on limited visibility at Bernstein
11/01/22 Bernstein
Cronos Group initiated with a Market Perform at Bernstein
GDNSF Goodness Growth
/

+

11/16/22 Canaccord
Goodness Growth price target lowered to C$0.85 from C$1 at Canaccord
10/14/22 Alliance Global Partners
Verano Holdings price target lowered to C$12 from C$16 at Alliance Global
05/12/22 Canaccord
Goodness Growth price target lowered to C$3.50 from C$4 at Canaccord
GTBIF Green Thumb Industries
$8.38 /

-0.12 (-1.41%)

12/01/22 Wedbush
Wedbush starts Green Thumb with Outperform, names top cannabis pick
12/01/22 Wedbush
Green Thumb Industries initiated with an Outperform at Wedbush
11/03/22 Stifel
Green Thumb Industries price target raised to C$31 from C$30.50 at Stifel
IGC India Globalization Capital
/

+

TLRY Tilray
$2.94 /

-0.12 (-3.92%)

01/10/23 MKM Partners
Tilray price target lowered to $3 from $4 at MKM Partners
01/10/23 Canaccord
Tilray price target lowered to $5 from $7 at Canaccord
01/09/23 Alliance Global Partners
Tilray price target lowered to $3 from $4 at Alliance Global Partners
12/28/22 Piper Sandler
Tilray estimates lowered on softer beer sales at Piper Sandler
CANN Trees Corporation
/

+

TCNNF Trulieve Cannabis
$7.05 /

-0.194 (-2.68%)

12/01/22 Wedbush
Wedbush starts Trulieve with Outperform on broadening reach
12/01/22 Wedbush
Trulieve Cannabis initiated with an Outperform at Wedbush
11/10/22 Canaccord
Trulieve Cannabis price target lowered to C$50 from C$54 at Canaccord
ZYNE Zynerba
/

+

06/23/22 Canaccord
Zynerba price target raised to $11 from $9 at Canaccord
ZYNE Zynerba
/

+

TLRY Tilray
$2.94 /

-0.12 (-3.92%)

RLMD Relmada Therapeutics
$4.42 /

+0.135 (+3.15%)

CRON Cronos Group
$2.43 /

-0.05 (-2.02%)

CMPS Compass Pathways
$9.75 /

-0.26 (-2.60%)

CGC Canopy Growth
$2.61 /

-0.055 (-2.07%)

ATAI Atai Life Sciences
$1.94 /

-0.065 (-3.24%)

ACB Aurora Cannabis
/

+

  • 27
    May
ATAI Atai Life Sciences
$1.94 /

-0.065 (-3.24%)

ACB Aurora Cannabis
/

+

TRYPF Tryp Therapeutics
/

+

RLMD Relmada Therapeutics
$4.42 /

+0.135 (+3.15%)

ATAI Atai Life Sciences
$1.94 /

-0.065 (-3.24%)

TLRY Tilray
$2.94 /

-0.12 (-3.92%)

RLMD Relmada Therapeutics
$4.42 /

+0.135 (+3.15%)

CGC Canopy Growth
$2.61 /

-0.055 (-2.07%)

ACB Aurora Cannabis
/

+

Options
Largest borrow rate increases among liquid names » 08:45
01/19/23
01/19
08:45
01/19/23
08:45
FRO

Frontline

$13.60 /

-0.53 (-3.75%)

, APPH

AppHarvest

$1.40 /

-0.14 (-9.09%)

, MARA

Marathon Digital

$6.90 /

-1.485 (-17.72%)

, JSPR

Jasper Therapeutics

$1.75 /

-0.14 (-7.41%)

, BBAI

BigBear.ai

$1.94 /

+0.065 (+3.48%)

, KBE

KBW Bank ETF

$45.70 /

-1.38 (-2.93%)

, ZIM

ZIM Integrated

$18.06 /

+0.15 (+0.84%)

, STLA

Stellantis

$15.28 /

-0.175 (-1.13%)

, SNDL

Sundial Growers

$2.30 /

-0.07 (-2.96%)

, FSM

Fortuna Silver Mines

$3.49 /

-0.055 (-1.55%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: Frontline (FRO) 3.30% +2.14, AppHarvest (APPH) 107.73% +1.86, Marathon Patent Group (MARA) 35.96% +1.31, Jasper Therapeutics (JSPR) 100.82% +0.85, BigBearai Holdings (BBAI) 159.96% +0.66, SPDR S&P Bank (KBE) 1.56% +0.31, ZIM Integrated Shipping Services (ZIM) 8.73% +0.21, Stellantis NV (STLA) 0.36% +0.11, Sundial Growers (SNDL) 6.18% +0.10, and Fortuna Silver Mines (FSM) 1.01% +0.09.

ShowHide Related Items >><<
ZIM ZIM Integrated
$18.06 /

+0.15 (+0.84%)

STLA Stellantis
$15.28 /

-0.175 (-1.13%)

SNDL Sundial Growers
$2.30 /

-0.07 (-2.96%)

MARA Marathon Digital
$6.90 /

-1.485 (-17.72%)

JSPR Jasper Therapeutics
$1.75 /

-0.14 (-7.41%)

FSM Fortuna Silver Mines
$3.49 /

-0.055 (-1.55%)

FRO Frontline
$13.60 /

-0.53 (-3.75%)

BBAI BigBear.ai
$1.94 /

+0.065 (+3.48%)

APPH AppHarvest
$1.40 /

-0.14 (-9.09%)

FRO Frontline
$13.60 /

-0.53 (-3.75%)

01/12/23 Deutsche Bank
Frontline price target raised to $16.50 from $15 at Deutsche Bank
01/11/23 JonesResearch
Euronav NV upgraded to Buy from Hold at JonesResearch
01/10/23 Stifel
Euronav NV downgraded to Hold from Buy at Stifel
11/29/22 Jefferies
Frontline price target raised to $17 from $16 at Jefferies
APPH AppHarvest
$1.40 /

-0.14 (-9.09%)

12/02/22 Oppenheimer
AppHarvest downgraded to Perform from Outperform at Oppenheimer
02/22/22 Barclays
AppHarvest price target lowered to $5.50 from $13 at Barclays
MARA Marathon Digital
$6.90 /

-1.485 (-17.72%)

01/12/23 DA Davidson
Marathon Digital price target lowered to $12 from $18 at DA Davidson
01/09/23 Jefferies
Marathon Digital downgraded to Hold from Buy at Jefferies
11/08/22 Jefferies
Marathon Digital price target lowered to $12.50 from $24 at Jefferies
10/25/22 Compass Point
Marathon Digital price target lowered to $21 from $30 at Compass Point
JSPR Jasper Therapeutics
$1.75 /

-0.14 (-7.41%)

11/14/22 Oppenheimer
Jasper Therapeutics price target lowered to $8 from $21 at Oppenheimer
10/31/22 EF Hutton
Jasper Therapeutics initiated with a Buy at EF Hutton
02/28/22 Cantor Fitzgerald
Jasper Therapeutics initiated with an Overweight at Cantor Fitzgerald
02/28/22 Cantor Fitzgerald
Jasper Therapeutics initiated with an Overweight at Cantor Fitzgerald
BBAI BigBear.ai
$1.94 /

+0.065 (+3.48%)

08/10/22 Oppenheimer
Oppenheimer downgrades BigBear.ai to Perform following 'disappointing' quarter
08/10/22 Oppenheimer
BigBear.ai downgraded to Perform from Outperform at Oppenheimer
03/28/22 Oppenheimer
BigBear.ai initiated with an Outperform at Oppenheimer
02/09/22 William Blair
BigBear.ai initiated with a Market Perform at William Blair
KBE KBW Bank ETF
$45.70 /

-1.38 (-2.93%)

ZIM ZIM Integrated
$18.06 /

+0.15 (+0.84%)

11/18/22 Barclays
ZIM Integrated price target lowered to $26.50 from $63 at Barclays
09/20/22 Goldman Sachs
ZIM Integrated price target lowered to $30 from $60 at Goldman Sachs
08/23/22 Citi
ZIM Integrated downgraded to Neutral from Buy at Citi
08/19/22 Barclays
ZIM Integrated price target lowered to $63 from $76 at Barclays
STLA Stellantis
$15.28 /

-0.175 (-1.13%)

11/30/22 Jefferies
Rio Tinto added to 'Franchise Picks' list at Jefferies
10/20/22 Nomura
Stellantis upgraded to Buy at Nomura amid 'appropriately paced' EV rollout
10/20/22 Nomura
Stellantis upgraded to Buy from Neutral at Nomura
10/14/22 Berenberg
Stellantis price target lowered to EUR 19 from EUR 21 at Berenberg
SNDL Sundial Growers
$2.30 /

-0.07 (-2.96%)

08/16/22 Canaccord
Sundial Growers upgraded to Speculative Buy from Hold at Canaccord
05/03/22 BMO Capital
Sundial Growers upgraded to Market Perform from Underperform at BMO Capital
05/03/22 BMO Capital
Sundial Growers upgraded to Market Perform from Underperform at BMO Capital
FSM Fortuna Silver Mines
$3.49 /

-0.055 (-1.55%)

01/13/23 National Bank
Fortuna Silver Mines price target raised to C$6 from C$5.25 at National Bank
12/06/22 BMO Capital
Fortuna Silver Mines price target raised to C$6 from C$5.75 at BMO Capital
11/11/22 BMO Capital
Fortuna Silver Mines price target raised to C$5.75 from C$5.25 at BMO Capital
10/13/22 National Bank
Fortuna Silver Mines price target raised to C$4.75 from C$4.25 at National Bank
ZIM ZIM Integrated
$18.06 /

+0.15 (+0.84%)

STLA Stellantis
$15.28 /

-0.175 (-1.13%)

SNDL Sundial Growers
$2.30 /

-0.07 (-2.96%)

MARA Marathon Digital
$6.90 /

-1.485 (-17.72%)

JSPR Jasper Therapeutics
$1.75 /

-0.14 (-7.41%)

FSM Fortuna Silver Mines
$3.49 /

-0.055 (-1.55%)

FRO Frontline
$13.60 /

-0.53 (-3.75%)

BBAI BigBear.ai
$1.94 /

+0.065 (+3.48%)

APPH AppHarvest
$1.40 /

-0.14 (-9.09%)

STLA Stellantis
$15.28 /

-0.175 (-1.13%)

MARA Marathon Digital
$6.90 /

-1.485 (-17.72%)

ZIM ZIM Integrated
$18.06 /

+0.15 (+0.84%)

STLA Stellantis
$15.28 /

-0.175 (-1.13%)

SNDL Sundial Growers
$2.30 /

-0.07 (-2.96%)

MARA Marathon Digital
$6.90 /

-1.485 (-17.72%)

FRO Frontline
$13.60 /

-0.53 (-3.75%)

BBAI BigBear.ai
$1.94 /

+0.065 (+3.48%)

ZIM ZIM Integrated
$18.06 /

+0.15 (+0.84%)

SNDL Sundial Growers
$2.30 /

-0.07 (-2.96%)

MARA Marathon Digital
$6.90 /

-1.485 (-17.72%)

KBE KBW Bank ETF
$45.70 /

-1.38 (-2.93%)

FSM Fortuna Silver Mines
$3.49 /

-0.055 (-1.55%)

FRO Frontline
$13.60 /

-0.53 (-3.75%)

BBAI BigBear.ai
$1.94 /

+0.065 (+3.48%)

APPH AppHarvest
$1.40 /

-0.14 (-9.09%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.